Utilization and impact of 21-gene recurrence score assay for breast cancer in clinical practice across the United States: lessons learned from the 2010 to 2012 National Cancer Data Base analysis
Crossref DOI link: https://doi.org/10.1007/s10549-016-3833-9
Published Online: 2016-05-20
Published Print: 2016-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Orucevic, Amila
Heidel, Robert E.
Bell, John L.
License valid from 2016-05-20